In three CRC patients, low frequencies of CD86 expression on tumor-associated ILCs were observed (Supplementary Fig. 6), suggesting that ILCs may, under certain circumstances, acquire antigen-presenting characteristics in vivo. Here, CD86 is linked to neoplasm.